Yasho Industries Ltd Q1 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/ezdwfgabm0c4z1jmz9822vqs.pdf

Key Takeaways


Revenue Growth & Volume Dynamics

Parag Jhaveri: "When we are talking, yes, I think we talk 40% guidance is very much with the current market trend only. So we are very confident despite recent turmoil in the tariff statement, we are still confident that we'll be able to achieve this 40% growth, at least 40% growth."

Margin Structure & Trade-offs

Parag Jhaveri: "currently, the geopolitical situation that we try to hold on our business rather to go for a higher margin. So currently, that's not the situation where we said that, yes, we'll be able to increase our EBITDA beyond 19%."

Pakhajan Ramp-Up & Capacity Expansion


Balance Sheet & Working Capital

Parag Jhaveri: "Good inventory should be the 110 to 120 days, but we need to bring it back. We are growing. We need to hold inventory. Currently, the customers are asking material on call. They don't give you the longer lead time. So, because of that, we need to carry unusually high inventory, and we hope the situation change sooner."

Tariffs, Pricing Power & Competitive Positioning

Parag Jhaveri: "We are trying to gain only about 0.2% of that. We aspire to go to INR900 crores to INR1,000 crores this year. So we are not looking at a very huge market share, very, very nominal market share."

R&D, Supply Chain & Strategic Initiatives


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growthAt least 40% YoY growth in FY26FY26 full year
EBITDA marginHold in 17–19% range; not exceeding 19%FY26 full year
Gross margin40% plus/minus 1–2% (raw material to finished goods)Ongoing
Fixed asset turnover3xBy FY27
Net working capital (inventory days)Reduce from 190 days to below 150 daysNot specified
Debt-to-EBITDABelow 3xBy FY27
Pakhajan utilization70–80%By Q4 FY26
Capacity expansion (₹75 cr) commissioningCommission by Jan/Feb; revenue from Q1 FY27Jan/Feb 2026
R&D laboratory completionState-of-the-art facility operationalOctober 2025
Fourth Pakhajan product commissioningCommission the remaining productBy end of 2025
Long-term debt-to-EBITDAComfortable at 2.5xLong-term
Export revenue shareGrow to 70% of total revenueGoing forward

Key Metrics

MetricQ1 FY26
Revenue₹198.6 cr, highest ever quarterly revenue, +14% YoY
Volume growth33% YoY
Standalone EBITDA margin18.01%
Consolidated EBITDA margin17.02% (corrected from 17.05% stated on call)
Gross margin~40%, down from peak of ~45% in Sep/Dec quarters; guided range 38% to 40%
Industrial Chemicals EBITDA marginMore than 20%
Consumer Chemicals EBITDA marginSingle digit
Industrial Chemicals revenue share87% of total revenue
Consumer Chemicals revenue share13% of total revenue
Revenue growth guidance for FY26At least 40%, based on current market trends
Pakhajan plant utilizationOver 50% during the quarter, more than about 55%
Vapi plant utilization70% to 75%
Capex incurred in Q1 FY26₹30 cr out of planned annual capex of ₹100 cr
FY26 planned capex₹100 cr, comprising ₹75 cr for plant and machinery capacity increase and ₹25 cr for R&D facility
Net working capital (inventory days)190 days, down from more than 200 days; target below 150 days
US revenue share25% of total revenue
Auto and auto ancillary revenue contribution~25%
Revenue per kg (aggregate)~₹400 per kilo
Average selling price per kg (Pakhajan)~₹200 per kilo
Long-term borrowing₹333.28 cr (corrected from ₹280 cr stated on call)
Short-term borrowing₹210.98 cr (corrected from ₹100 cr stated on call)
Debt-to-EBITDA targetBelow 3 by FY27; comfortable range of 2.5x in the long-term
Tax rate~30% (29-point-something)
Export revenue share expectation70% of total revenue going forward, up from 67%
R&D facility completion timelineOctober 2025
Fixed asset turnover target3x by FY27